CLINICAL ROLE -
Insurance Claims May Model Anti-HER2 Chemo Demand
A study including 10 million patients covered by 11 health plans suggested that insurance claims could be used to estimate the number of early-stage breast cancer cases as well as the demand for anti-HER2 drugs.
Read More
First Biosimilar Monoclonal Antibody Therapy Approved in Europe
Inflectra was approved for treatment of inflammatory conditions by the European Medicines Agency based on evidence that it was as effective, safe, and tolerable as its reference drug, Remicade.
Men Favor Prostate Cancer Test Despite Task Force Recommendation
In a recent study, a majority of men reported they still wanted to receive prostate-specific antigen testing, despite recommendations by the US Preventative Services Task Force (USPSTF) against the test.
Pharmacists Ready to Help with OTC HIV Test
Community pharmacists interviewed for a recently published study were eager to play a role in counseling patients who use over-the-counter HIV tests.
Task Force Recommends Hepatitis C Testing for Baby Boomers
The U.S. Preventive Services Task Force recommends that all patients born between 1945 and 1965 as well as high-risk patients of all ages be tested for hepatitis C.